Related Experiment Video
Updated: May 6, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Vitamin d and pancreatic cancer-an update
Kun-Chun Chiang1, Chun-Nan Yeh, Tai C Chen
1Department of Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taiwan. taichen@bu.edu.
Abstract:
The non-classical actions of vitamin D, namely anti-proliferation, pro-differentiation, immune function modulation, and anti-inflammation, have received great attention during the past decade, in particular, the potential of vitamin D analogs alone or in combination with other anticancer agents for the treatment of a variety of cancers. The association between vitamin D status and the higher incidence of many forms of cancer has suggested that vitamin D may play a role in the etiology of these types of cancer. Although it is still controversial whether this association exists for pancreatic cancer, biochemical evidence clearly indicates pancreatic cancer cells are responsive to the inhibitory effect of vitamin D and its analogs. In this review, we discuss briefly the origin and current therapy of pancreatic cancer, the history, source, metabolism and functions of vitamin D, the recent progress in the epidemiological studies of sunlight, and vitamin D status, and biochemical studies of vitamin D analogs in the prevention and treatment of pancreatic cancer.
Insights
Vitamin D and its analogs show potential in inhibiting pancreatic cancer cell growth. Further research into vitamin D
Area of Science:
- Oncology
- Endocrinology
- Nutritional Science
Background:
- Non-classical vitamin D actions (anti-proliferation, immune modulation) are key in cancer research.
- Vitamin D's role in various cancer etiologies is increasingly recognized.
- Pancreatic cancer cells exhibit sensitivity to vitamin D's inhibitory effects.
Purpose of the Study:
- To review the therapeutic potential of vitamin D analogs in pancreatic cancer.
- To explore the link between vitamin D status and pancreatic cancer.
- To summarize biochemical and epidemiological evidence regarding vitamin D and pancreatic cancer.
Main Methods:
- Literature review of epidemiological and biochemical studies.
- Analysis of vitamin D metabolism and functions.
- Examination of current pancreatic cancer therapies.
Main Results:
- Biochemical data support vitamin D's inhibitory effect on pancreatic cancer cells.
- Epidemiological evidence on vitamin D and pancreatic cancer remains under investigation.
- Vitamin D analogs show promise as anticancer agents.
Conclusions:
- Vitamin D analogs warrant further investigation for pancreatic cancer prevention and treatment.
- Understanding vitamin D's role could lead to novel therapeutic strategies.
- Combination therapies involving vitamin D analogs may enhance efficacy.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis II: Pathophysiology
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Cancer Prevention
Some...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...

